References
- Smith O. P., Prentice H. G., Hazlehurst G., Brozovic B., Hoffbrand A. V., Mehta A. B. Blood product support in patients undergoing chemotherapy and autologous or allogeneic bone marrow transplantation for haematological malignancies. Clin Lab Haematol 1991; 13: 107–114
- Levin M. J. Current approaches to the prevention and treatment of cytomegalovirus disease after bone marrow transplantation: an overview. Sem Hematol 1990; 27(Suppl 1)1–4
- Anderson K. C., Goodnough L. T., Sayers M., Pisciotto P. T., Kurtz S. R., Laqne T. A., Anderson C. S., Silberstein L. E. Variation in blood component irradiation practice: implications for prevention of transfusion-associated graft-versus-host disease. Blood 1991; 77: 2069–2102
- Aurer I., Ribas A., Gale R. P. What is the role of recombinant colony stimulating factors in bone marrow transplantation?. Bone Marrow Transpl 1990; 6: 79–87
- Vannucchi A. M., Bosi A., Grossi A., Guidi S., Saccardi R., Lombardini L., Rossi Ferrini P. Stimulation of erythroid engraftment by recombinant human erythropoietin in ABO-compatible, HLA-identical, allogeneic bone marrow transplant patients. Leukemia 1992, In press
- Abedi M. R., Backman L., Bostrom L., Lindback B., Ringden O. Markedly increased serum erythropoietin levels following conditioning for allogeneic bone marrow transplantation. Bone Marrow Transpl 1990; 6: 121–126
- Ireland R. M., Atkinson K., Concannon A., Dodds A., Down K., Biggs J. C. Serum erythropoietin changes in autologous and allogeneic bone marrow transplant patients. Brit J Haematol 1990; 76: 128–134
- Schapira L., Antin J. H., Ransil B. J., Antman K. H., Eder P. J., McGarigle C. J., Goldberg M. A. Serum erythropoietin levels in patients receiving intensive chemotherapy and radiotherapy. Blood 1990; 76: 2354–2359
- Beguin Y., Clemons G. K., Oris R., Fillet G. Circulating erythropoietin levels after bone marrow transplantation: inappropriate response to anemia in allogeneic transplants. Blood 1991; 77: 868–873
- Bosi A., Vannucchi A. M., Grossi A., Guidi S., Saccardi R., Rafanelli D., Longo G., Rossi Ferrini P. Inadequate erythropoietin production in allogeneic bone marrow transplant patients. Haematologica 1991; 76: 280–284
- Bosi A., Vannucchi A. M., Grossi A., Guidi S., Vannucchi L., Saccardi R., Bernabei P. A., Longo G., Rafanelli D., Rossi Ferrini P. Serum erythropoietin levels in patients undergoing autologous bone marrow transplantation. Bone Marrow Transpl 1991; 7: 421–425
- Vannucchi A. M., Grossi A., Bosi A., Rafanelli D., Guidi S., Saccardi R., Alterini R., Rossi Ferrini P. Impaired erythropoietin production in mice treated with cyclosporin A. Blood 1991; 78: 1615–1618
- Link H., Diedrich H., Ebell W., Bucksky P., Peest D., Stoll M., Freund M., Brune H., Poliwoda H. Recombinant human erythropoietin after allogeneic bone marrow transplantation (abstract). Bone Marrow Transpl 1990; 5(Suppl 2)225a
- Miller C. B., Huelskamp A. M., Mills S. R., Jones R. J. A pilot trial of recombinant human erythropoietin (rhEpo) after alogeneic bone marrow transplantation (alloBMT) (abstract). Exp Hematol 1991; 19(6)455
- Lopez J., Steegmann J. L., Berberana M., Lamana M., Otero M. J., Camara R., Tomas J. F., Diaz A., Femandez-Ranada J. M. Use of recombinant human erythropoietin in allogeneic bone marrow transplantation. Preliminary results of a prospective and randomized study (abstract). Schweiz med Wschr 1991; 121(Suppl 43)395a